Status:
COMPLETED
Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)
Lead Sponsor:
Peking University Cancer Hospital & Institute
Conditions:
Breast Neoplasms
Neoplasm Metastasis
Eligibility:
FEMALE
18-70 years
Brief Summary
The investigators want to know the role of Peripheral hematopoietic stem cell infusion in avoiding Drug Induced Liver Injury,and also try to research SNPs genotyping associated with Drug Induced Liver...
Detailed Description
1. The researcher investigate the incidence and the cause of Drug Induced Liver Injury in MBC. 2. Patients having a complete clinical history and physical examination, receive routine chemotherapy. 3....
Eligibility Criteria
Inclusion
- Patients should be histologically confirmed with metastatic breast cancer;
- an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2;
- Normal cardiac, hepatic, renal and bone marrow functions;
- Life expectancy ≥3 months;
Exclusion
- previous history of other malignancies;
- Central nervous system metastases;
- Serious or uncontrolled concurrent medical illness.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01231022
Start Date
August 1 2010
End Date
June 1 2013
Last Update
July 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, China, 100142